Comparison of Immune Profiles in Chronic Rhinosinusitis Patients After Mepolizumab Treatment

Status: Recruiting
Location: See location...
Intervention Type: Other, Biological
Study Type: Interventional
Study Phase: Phase 4
SUMMARY

This study aims to analyze the immune profiles of patients with Chronic Rhinosinusitis with Nasal polyps (CRSwNP) with and without asthma before and after Mepolizumab. A group of participants with CRS without nasal polyps (CRSsNP) with asthma will be included to compare their immune profiles to CRSwNP.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 19
Healthy Volunteers: f
View:

• Are over the age of 19.

• Patients with CRSwNP with or without asthma:

‣ Asthma confirmed with a spirometry and assessment on previous history of asthma (a methacholine challenge test and atopy testing to document positive or negative history of asthma will be performed if there is no clinical record).

⁃ Presence or absence of nasal polyps. This can be based on formal exam at Baseline Visit or historical assessment.

• Patients with CRSsNP with asthma:

‣ These patients will not take the study treatment and they will only complete screening and baseline visits.

• Females of childbearing potential must commit to using an acceptable method of birth control for the duration of the study and they must have a negative urine pregnancy test at each study visit.

Locations
Other Locations
Canada
St. Pual's Sinus Centre
RECRUITING
Vancouver
Contact Information
Primary
Atenea Pascual, PhD
apascual@providencehealth.bc.ca
604-806-9926
Time Frame
Start Date: 2023-07-01
Estimated Completion Date: 2025-06-30
Participants
Target number of participants: 90
Treatments
Experimental: Mepolizumab
Mepolizumab (100 mg) subcutaneously every 4 weeks
Placebo_comparator: Placebo
Placebo 100 mg subcutaneously every 4 weeks
Sponsors
Leads: St. Paul's Sinus Centre

This content was sourced from clinicaltrials.gov

Similar Clinical Trials